Viral Clearance Market Worth 510.3 Million USD by 2020 - PowerPoint PPT Presentation

About This Presentation
Title:

Viral Clearance Market Worth 510.3 Million USD by 2020

Description:

Viral Clearance Market was valued at USD 285.5 Million in 2015. This market is expected to grow at a CAGR of 12.3% to reach USD 510.3 Million in 2020. – PowerPoint PPT presentation

Number of Views:4

less

Transcript and Presenter's Notes

Title: Viral Clearance Market Worth 510.3 Million USD by 2020


1
Viral Clearance Market Worth 510.3 Million USD by
2020
www.MarketsandMarkets.com
2
According to a new market research report "Viral
Clearance Market by Application (Stem Cell,
Blood, Tissue, Cell Gene Therapy), Method
(Inactivation, Removal (Precipitation), Detection
(PCR, ELISA)) End User (Pharmaceutical
Biotechnology, CROs, Research Institute) - Global
Forecast to 2020", published by
MarketsandMarkets, the global market was valued
at USD 285.5 Million in 2015. This market is
expected to grow at a CAGR of 12.3 to reach USD
510.3 Million in 2020.
3
Browse 76 market data Tables and 89 Figures
spread through 165 Pages and in-depth TOC on
"Viral Clearance Market http//www.marketsandmar
kets.com/Market-Reports/viral-clearance-market-626
81197.html Early buyers will receive 10
customization on this report.  The global Viral
Clearance Market is segmented on the basis of
method, end user, application, and geography. By
method, the market is divided into viral
detection method, viral removal method, and viral
inactivation method. Of these, the viral
detection method segment accounted for the
largest share of the global Viral Clearance
Market in 2015. The application segments included
in this report are blood blood products,
cellular gene therapy products, stem cell
products, tissue tissue products, and vaccines
and therapeutics. Of these the vaccines and
therapeutics application hold the highest share.
By end user, the market is segmented into
pharmaceutical and biotechnology companies,
contract research organizations, academic
research institutes, and other end users. Other
end user segment primarily includes medical
device companies, cell banks, small cell culture
laboratories and consultants, microbiology
laboratories, immunology laboratories, molecular
laboratories, animal facilities, toxicology
laboratories, and media/sera manufacturers.
4
The geographic segments included in this report
are Asia, Europe, North America, and the Rest of
the World (RoW). The North America segment is
further divided into Canada and the U.S. Rapidly
increasing pharmaceutical and biotechnology
industries and increasing number of new biologics
products launched will be the two most important
growth drivers for this market in the forecasted
period (2015-2020). For instance, the number of
new biologics products launched annually
witnessed a strong upward trend between 2003 and
2013. The number of new products launched in 2013
was 56 as compared to 29 in 2003. The biologics
pipeline has increased by 155, from 355
treatments in 2001 to 907 in 2012. A
complete brochure for this research is available
_at_ http//www.marketsandmarkets.com/pdfdownload.asp
?id62681197
5
A strong pharmaceutical product pipeline will aid
the growth of the pharmaceutical and
biotechnology industry, which is an important end
user of viral clearance products. Moreover,
increasing government support for the
pharmaceutical and biotechnology industries will
further boost the demand for viral clearance
products. For instance, in 2013, the European
Research Council awarded a fund of USD 830
million for life sciences research projects
across Europe. A similar trend can be observed in
Asia. For instance, beginning in 2014, the Indian
government plans to invest up to USD 5 billion a
year for the next five years, to boost the
biotechnology sector in the country and make it a
USD 100 billion industry by 2025. These funding
activities help in increasing the purchasing
power of major research institutes, which in turn
is driving the market for viral clearance
products. Major players in the Viral Clearance
Market include Avance Biosciences Inc. (U.S.),
BSL BIOSERVICE (Germany), Clean Cells (France),
Charles River Laboratories International, Inc.
(U.S.), Lonza Group (Switzerland), Merck Co.,
Inc. (U.S.), Sigma-Aldrich Corporation (U.S.),
SGS S.A. (Switzerland), Texcell, Inc. (France),
and WuXi PharmaTech (Cayman) Inc. (China).
6
Browse Related Reports  Biological Safety
Testing Market by Application (Stem Cell, Blood,
Gene Therapy), Product (Instruments, Services,
Kits, Reagents), Test (Bioburden, Endotoxin,
Cell Line Authentication, Residual Contamination,
Adventitious Agents) - Global Forecast to
2019. http//www.marketsandmarkets.com/Market-Repo
rts/biologics-safety-testing-market-34624144.html
Pyrogen Testing Market by Product (Instruments,
Services, Kits Reagents), by Test (In Vitro,
LAL, Rabbit Test), by Application (Pharmaceutical
Biotechnology Companies, Medical Devices, Other
Applications) - Global Forecast to
2019. http//www.marketsandmarkets.com/Market-Repo
rts/pyrogen-testing-market-255266155.html
7
About Report Publisher MarketsandMarkets is
the worlds No. 2 firm in terms of annually
published premium market research reports.
Serving 1700 global fortune enterprises with more
than 1200 premium studies in a year, MM is
catering to a multitude of clients across 8
different industrial verticals. We specialize in
consulting assignments and business research
across high growth markets, cutting edge
technologies and newer applications.
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence
repository. Annual Market Research Reports
Subscription - http//www.marketsandmarkets.com/Su
bscription.html Contact Mr. Rohan Markets and
Markets UNIT no 802, Tower no. 7, SEZ Magarpatta
city, Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441
Write a Comment
User Comments (0)
About PowerShow.com